Inventor · disambiguated record

Thach Mai

Also filed as: MAI THACH

3 granted patents·9 pending applications·3 citations·filing 2019–2024

57Inventor score

Technology areasA61K C07K

Files withJUVENA THERAPEUTICS INC12

Top patents by PatentIndex Score

12 records

0183US10821155B2Heparin-associated polypeptides and uses thereofJUVENA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·3 cites·14 claims
0276US12329801B2Regenerative polypeptides and uses thereofJUVENA THERAPEUTICS INC·Filed 2024·Granted Jun 17, 2025·0 cites·12 claims
0376US2025241991A1Heparin-associated polypeptides and uses thereofJUVENA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
0474US2024043484A1Regenerative polypeptides and uses thereofJUVENA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
0573US2024024423A1Heparin-Associated Polypeptides and Uses ThereofJUVENA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
0671US2023312663A1Regenerative Polypeptides and Uses ThereofJUVENA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
0764US12358963B2Regenerative polypeptides and uses thereofJUVENA THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·20 claims
0862US2022409696A1Heparin-Associated Polypeptides and Uses ThereofJUVENA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
0961US2021038693A1Heparin-Associated Polypeptides and Uses ThereofJUVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
1060US2025090633A1Therapeutic compositions and methods of use thereofJUVENA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
1152US2023405089A1Heparin-Associated Polypeptides and Uses ThereofJUVENA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
1242US2024189397A1Heparin-Associated Polypeptides and Uses ThereofJUVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Thach Mai files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →